Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

SAMHSA Proposes to Update OUD Treatment Standards

A proposed rule from the Substance Abuse and Mental Health Services Administration (SAMHSA) focuses on increasing access to treatment for opioid use disorder and updating outdated definitions and standards of treatment in opioid treatment programs.

The rule will make permanent a COVID-19 public health emergency flexibility to allow providers to initiate buprenorphine prescriptions for new patients through telehealth. Previously, rules required an in-person medical evaluation before a patient could be prescribed buprenorphine. Further, SAMHSA proposes to eliminate reporting requirements for practitioners who have a waiver to prescribe buprenorphine for up to 275 patients.

Comments are due Feb. 14, 2023.

Contact Senior Director of Policy Erin O’Malley at or 202.585.0127 with questions.


About the Author

Julie Kozminski is a senior policy analyst at America's Essential Hospitals.

where to buy viagra
buy lasix
buy doxycycline
buy trazodone
buy famvir
buy metoprolol
where to buy methylprednisolone
where to buy disulfiram
canadian pharmacy
buy albuterol inhaler
buy cialis online
prednisone otc
where to buy accutane
buy abilify
buy domperidone
buy neurontin
where to buy zithromax online
buy synthroid
ivermectin otc
buy strattera online
metformin otc
clomid online
nitrofurantoin otc
online drugstore
where to buy flagyl
where to buy diflucan
mexican pharmacy
misoprostol online
discount pharmacy
buy zoloft online
citalopram online
hydroxyzine online
kaletra online
Previous Next
Test Caption
Test Description goes like this